Page last updated: 2024-08-25

9,11-linoleic acid and Alloxan Diabetes

9,11-linoleic acid has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, T; Fujii, A; Nestel, P	1

Other Studies

1 other study(ies) available for 9,11-linoleic acid and Alloxan Diabetes

Article	Year
The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis, 2006, Volume: 189, Issue:2 Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Experimental; Disease Progression; Linoleic Acids, Conjugated; Mice; Mice, Inbred C57BL; Mice, Knockout; Treatment Outcome; Triglycerides; Ultracentrifugation	2006

Article

Year

The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice.

Atherosclerosis, 2006, Volume: 189, Issue:2

Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Experimental; Disease Progression; Linoleic Acids, Conjugated; Mice; Mice, Inbred C57BL; Mice, Knockout; Treatment Outcome; Triglycerides; Ultracentrifugation

2006